Acute Coronary Syndromes (ACS) 2025 Updates

Newark, DE US
November 11, 2025

This session will provide an overview of the AHA/ACC 2025 ACS guidelines, with a focus on updates most relevant to pharmacy practice. Participants will review changes in diagnostic and treatment recommendations, emphasizing updates in pharmacologic management, including antiplatelet, anticoagulant, and lipid-lowering therapies. The session will also highlight evidence that informed these recommendations, supporting pharmacists and pharmacy technicians in optimizing medication therapy and improving patient outcomes in ACS management.

Target Audience

  • Pharmacists
  • Pharmacy Technicians

Learning Objectives

Pharmacists

At the conclusion of this activity, pharmacists should be able to:

  • Review ACS basics including diagnosis and medication therapy
  • Analyze key updates in medication recommendations from the AHA/ACCP 2025 ACS guidelines
  • Appraise literature pertaining to specific updates

 

 

Pharmacy Technicians

At the conclusion of this activity, pharmacy technicians should be able to:

  • Review ACS basics including diagnosis and medication therapy
  • Analyze key updates in medication recommendations from the AHA/ACCP 2025 ACS guidelines
  • Appraise literature pertaining to specific updates

 

Course summary
Available credit: 
  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Course opens: 
11/11/2025
Course expires: 
01/10/2026
Event starts: 
11/11/2025 - 12:00pm CST
Event ends: 
11/11/2025 - 1:00pm CST
Add to calendar: 
ChristianaCare
4755 Ogletown-Stanton Road
Newark, DE 19718
United States

FACULTY & PLANNERS

Faculty

Laura Zizza, PharmD, BCCP      
Cardiac ICU Clinical Pharmacy Specialist              
ChristianaCare 

Planners
Laura Zizza, PharmD, BCCP      
Cardiac ICU Clinical Pharmacy Specialist                             
ChristianaCare 
 
 
Marilu Kelly, MSN, RN, NPD-BC, CHCP
Director, Continuing Education       
Vizient, Inc.
 
Kim Bentley, CHCP   
CE Programs Manager              
Vizient, Inc.
 
DISCLOSURE
As an accredited provider of continuing education, Vizient, Inc. is dedicated to ensuring this activity presents learners with only accurate, balanced, scientifically justified recommendations, and is free from promotion, marketing, and commercial bias. In accordance with The Standards for Integrity and Independence in Accredited Continuing Education, all planners, faculty, and others in control of the educational content have disclosed the absence or existence of all financial relationships (of any dollar amount) with ineligible companies within the past 24 months.
 
Ineligible companies – those companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
It is Vizient’s policy that owners and employees of ineligible companies, and any individuals who refuse to disclose the absence or existence of financial relationships with any ineligible companies are disqualified from participating as planners or faculty.
 
Disclosure Statements
 
Absence of Relevant Financial Relationships
 
None of the planners, faculty, or others in a position to control content for this educational activity have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
 
 
 
Statement of Content Validity
 
Vizient, Inc. educational activities are intended to assist healthcare teams advance their professional responsibilities in accordance with the definition of continuing education. It is the policy of Vizient, Inc. to review and ensure that all content and recommendations for patient care within accredited CE is evidenced-based, based on current science and clinical reasoning while ensuring the content is fair and balanced. All recommendations must conform to the generally accepted standards of experimental design, data collection, analysis, and interpretation. Vizient, Inc. does not permit accredited continuing education if it advocates for unscientific approaches to diagnosis or therapy, or if the education promotes recommendations, treatment, or manners of practicing healthcare that are determined to have risks or dangers that outweigh the benefits or are known to be ineffective in the treatment of patients.
 
FDA Off-Label Use
 
Faculty presenters are also expected to disclose any discussion of (1) off-label or investigational uses of FDA approved commercial products or devices or (2) products or devices not yet approved in the United States.
 
Usage Disclosure: “Off-label/unapproved drug uses or products are mentioned within this activity.”
 
Evidence-based Content: “Low/absence of evidence-based topics are mentioned within this activity.”
 
Disclaimer
The education provided through this activity is for continuing education purposes only. The views and opinions expressed in this activity are those of the faculty/presenters and do not necessarily reflect the views of Vizient, Inc.

 

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by Vizient, Inc. and ChristianaCare. Vizient, Inc. is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

 

Designation Statement(s)

Pharmacists (CPE)

Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for pharmacists.

Universal Activity Number:  JA0006103-9999-25-299-L01-P

 

Pharmacy Technicians (CPE)

Vizient, Inc. designates this live activity for a maximum of 1.00 contact hours for pharmacy technicians.

Universal Activity Number: JA0006103-9999-25-299-L01-T
 
 
 

 

 

Available Credit

  • 1.00 ACPE Pharmacist
  • 1.00 ACPE Pharmacy Technician
Please login or register to take this course.

 

Select the “Obtain Credit” button to access the activity evaluation and to claim CE Credit.

Please Note: 

  • If the "Register/Take Course" tab is displayed instead of the "Obtain Credit" tab, you must first login to proceed with the credit claim process.
  • This activity requires learners to confirm their attendance using an activity code. An Access Denied error message indicates that your attendance was not recorded via SMS text or QR code scanning.

Please click here to enter the code you received at the end of the activity to verify your attendance if you have not already done so: https://continuingeducation.vizientinc.com/code

 

Required Hardware/software

 

The Vizient CE Learner Portal is compatible with most modern web browsers (such as Firefox, Google Chrome, Microsoft Edge, Apple Safari) and can also be accessed with mobile devices.